Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2014

May 28, 2014

34975_dirs_2014-05-28_b1e31602-9f30-4050-bbd9-5c7c1380fcd2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-05-23

Reporting Person: HARTE NEAL J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-23 Common Stock M 3303 $3.32 Acquired 24258 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-23 Stock option (right to buy) $3.32 M 3303 Disposed 2014-06-04 Common stock, par value $0.01 per share (3303) Direct

Footnotes

F1: Includes (a) a deferred stock award of 7,777 restricted stock units which shall fully vest on May 31, 2014; and (b) a deferred stock award of 7,377 restricted stock units which vest in equal installments on June 1, 2014 and June 1, 2015; and (c) 9,104 shares of common stock held by the Reporting Person.

F2: Represents exercise of stock options granted pursuant to the Isser's 2000 Stock Option and Incentive Plan, as amended.